BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35304261)

  • 1. The long-term prognosis of patients with untreated primary uveal melanoma: A systematic review and meta-analysis.
    Stålhammar G; Gill VT
    Crit Rev Oncol Hematol; 2022 Apr; 172():103652. PubMed ID: 35304261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization, treatment, and outcome of uveal melanoma in the first two years of life.
    Yousef YA; Alkilany M
    Hematol Oncol Stem Cell Ther; 2015 Mar; 8(1):1-5. PubMed ID: 25300563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New treatment modalities for uveal melanoma.
    De Potter P; Shields CL; Shields JA
    Curr Opin Ophthalmol; 1996 Jun; 7(3):27-32. PubMed ID: 10163456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bilateral uveal melanomas. Five case reports].
    Bhouri L; Lumbroso L; Levy C; Dendale R; Asselain B; Plancher C; Sastre X; Desjardins L
    J Fr Ophtalmol; 2003 Feb; 26(2):149-53. PubMed ID: 12660588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Analysis of Uveal Melanoma].
    Nezu N; Goto H; Umazume K; Ueda S; Shibata M
    Nippon Ganka Gakkai Zasshi; 2017 May; 121(5):413-8. PubMed ID: 30074750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma.
    Ophthalmic Oncology Task Force
    Ophthalmology; 2016 Jan; 123(1):86-91. PubMed ID: 26505803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features, Metastasis, and Survival in Patients Younger Than 21 Years With Posterior Uveal Melanoma.
    Fry MV; Augsburger JJ; Corrêa ZM
    JAMA Ophthalmol; 2019 Jan; 137(1):75-81. PubMed ID: 30422230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very long-term prognosis of patients with malignant uveal melanoma.
    Kujala E; Mäkitie T; Kivelä T
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4651-9. PubMed ID: 14578381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
    Frenkel S; Hendler K; Pe'er J
    Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
    Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
    Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic uveal melanoma: diagnosis and treatment. A literature review.
    De Croock L; Verbraeken H
    Bull Soc Belge Ophtalmol; 2002; (286):59-63. PubMed ID: 12564318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Metastatic Uveal Melanoma: From Diagnosis to Survival Four Years Later.
    Chandra S; McKean H
    S D Med; 2023 Mar; 76(3):120-123. PubMed ID: 36898198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin.
    Shields CL; Welch RJ; Malik K; Acaba-Berrocal LA; Selzer EB; Newman JH; Mayro EL; Constantinescu AB; Spencer MA; McGarrey MP; Knapp AN; Graf AE; Altman AJ; Considine SP; Shields JA
    Middle East Afr J Ophthalmol; 2018; 25(2):81-90. PubMed ID: 30122853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of posterior uveal melanoma: past, present, and future: the 2014 Charles L. Schepens lecture.
    Shields JA; Shields CL
    Ophthalmology; 2015 Feb; 122(2):414-28. PubMed ID: 25439609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on uveal melanoma: Translational research from biology to clinical practice (Review).
    Ortega MA; Fraile-Martínez O; García-Honduvilla N; Coca S; Álvarez-Mon M; Buján J; Teus MA
    Int J Oncol; 2020 Dec; 57(6):1262-1279. PubMed ID: 33173970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors for malignant uveal melanoma. Retrospective study on 2,241 patients and recent contribution of monosomy-3 research].
    Desjardins L; Levy-Gabriel C; Lumbroso-Lerouic L; Sastre X; Dendale R; Couturier J; Piperno-Neumann S; Dorval T; Mariani P; Salmon R; Plancher C; Asselain B
    J Fr Ophtalmol; 2006 Sep; 29(7):741-9. PubMed ID: 16988624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating Cured Fractions of Uveal Melanoma.
    Singh AD; Zabor EC; Radivoyevitch T
    JAMA Ophthalmol; 2021 Feb; 139(2):174-181. PubMed ID: 33355644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveal Melanoma Treatment and Prognostication.
    Dogrusöz M; Jager MJ; Damato B
    Asia Pac J Ophthalmol (Phila); 2017; 6(2):186-196. PubMed ID: 28399342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical spectrum, treatment and outcomes of uveal melanoma in a tertiary centre.
    Wong W; Sundar G; Chee C; Zhao PS; Rajagopalan R; Gopal L
    Singapore Med J; 2019 Sep; 60(9):474-478. PubMed ID: 31197380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in uveal melanoma.
    Singh AD; Shields CL; Shields JA
    Melanoma Res; 2001 Jun; 11(3):255-63. PubMed ID: 11468514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.